Case Study

Owlstone Medical

Owlstone’s mission is to save 100,000 lives and save health care providers $1.5B.

The team have developed patented technology which uses breath to analyse disease biomarkers. This enables non-invasive diagnostics for cancer, infectious and inflammatory diseases.

The company has a clear alignment to our health business and our focus on wellness and prevention.
Ben Luckett, Managing Director, Aviva Ventures

A deeper understanding of new and innovative technologies that detect disease will deliver greater insights into our health business and help us develop new products for our customers.

To learn more visit:

Back to Aviva Ventures home page

Case Studies


Shepper carries out Smart Asset Checks on properties and assets.